Michigan Model for Diabetes Home

The Michigan Model for Diabetes (MMD) is a computerized disease model that enables the user to simulate the progression of diabetes, its complications (retinopathy, neuropathy and nephropathy), and its major comorbidities (cardiovascular and cerebrovascular disease), and death. Transition probabilities can be a function of individual characteristics, risk factors, current disease states or treatment status. The model also estimates the medical costs of diabetes and its comorbidities, as well as the quality of life related to the current health state of the subject.

*NEW* On September 1, 2015 we launched version 2.0 of the MMD. New features of the MMD 2.0 include:

  1. Modeling disease progression as a function of the changes in multiple biomarkers and risk factors
  2. An updated coronary heart disease sub-model that incorporates the possibility of recurrence of myocardial infarction (MI), congestive heart failure, and cardiac procedures either before or after MI
  3. Modelling modern diabetes treatment regimens and management for dysglycemia, dyslipidemia, and hypertension
  4. Modeling the direct benefit of medication and compliance
  5. Updated transition probability tables for end stage renal disease
  6. Updated competing death table
  7. Updated cost and utility models

If you want to use version 2.0 please click here.

If you want to continue using version 1.0 please click here.

If you have any questions/issues please contact us at wye@umich.edu

Remember to cite the Michigan Center for Diabetes Translational Research (MCDTR) in publications as follows:
“The project described was supported by Grant Number P30DK092926 (MCDTR) from the National Institute of Diabetes and Digestive and Kidney Diseases”